Initial public offering of Oncopeptides AB (SE) on Nasdaq Stockholm — SEK 748 million

Carnegie acted as joint global co-ordinator and joint bookrunner in the initial public offering of Oncopeptides on Nasdaq Stockholm. Oncopeptides is a research and development stage pharmaceutical company developing drugs for treatment of cancer. February 2017.